Skip to main content

ANL · Adlai Nortye Group Ltd. · Holdings

Track ANL — free
$10.58 -0.68 (-6.04%) At close · Oct 22
Market Cap
$703.23M
Shares
64.40M
Volume · Oct 22 169.97K Avg daily vol (3M) 216.07K

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Recent SEC filings are still being reconciled. Holder totals and changes may be incomplete until processing catches up.
Holders: 42
Total Value: $304,298,440
Total Shares: 26,460,735

Institutional Ownership Trend

12 quarters

Holder Concentration

Across 42 13F filers · Δ vs Mar 31, 2026
Top Holder
15.0%
Sep 2023 → Jun 2026 · range 15.0% – 71.3%
−12.7 pts
Top 5
54.2%
Sep 2023 → Jun 2026 · range 54.2% – 100.0%
−23.0 pts
Top 10
76.1%
Sep 2023 → Jun 2026 · range 76.1% – 100.0%
−17.1 pts
HHI
776
Sep 2023 → Jun 2026 · range 776 – 5,870
Broadly held−896

Who Holds ANL

Last 8 quarters through Jun 30, 2026

Each kind of 13F filer's share of the common shares 13F filers report. Holder type comes from regulatory records, never the filer's name; style, turnover and horizon are measured from each filer's own 13F book. The quarter selector does not change this card.

Jun 30, 2026: 42 filers, like-for-like change +128.4%; actively managed books +128.5%; index-like books +27.3%.

Holder type Share Filers Change
Registered adviser 86.7% 29 +112.4%
Exempt adviser 1.0% 2 +462.3%
Adviser 7.6% 2 +1583.6%
Bank 0.2% 1 -56.7%
Holding company 0.0% 0 —
Unknown 4.4% 8 +137.6%
How the mix is measured

Shares are 13F common shares restated to today's split basis; options and principal amounts are left out. The change compares only filers with a 13F in both quarters and keeps each filer in its bucket of the later quarter on both sides; a filer that continues under a new CIK is compared through its successor. Holder type comes from each filer's current regulatory profile; client base and private funds come from the Form ADV roster current at each quarter end (rosters from December 2019, so an earlier quarter reads Unknown). Style, turnover, horizon and book size are measured from each filer's 13F book in the newest measured quarter, and Not measured means none was. Actively managed books are those measured systematic-like, concentrated or diversified active.

Conviction and Crowding

42 13F filers, quarter ended Jun 30, 2026

Measured across every 13F filer's common-share book once the quarter's filing window closed. Crowding counts filers with high turnover or that advise private funds on Form ADV.

Conviction holders
1
2.38% of filers hold it in their top 10
Mar 31, 2026: 1
Holders above 5%
0
median weight 0.076%
Mar 31, 2026: 0
Crowding
—
a foreign private issuer reports ordinary shares, a different unit from the listed shares
Private-fund advisers
—
of shares outstanding
Institutional ownership
—
a foreign private issuer reports ordinary shares, a different unit from the listed shares
Top 10 holders
76.1%
of 13F shares, Herfindahl 0.078
Active holders
+128.5%
like-for-like share change of active filers
5% stakes on record
6
0 13D, 6 13G (1 institutional, 1 passive, 4 exempt)
How long holders have held it value-weighted 1.6 quarters
Under 1 year 99.8% 1 to 3 years 0.200% 3 years or more 0.000% Since coverage start 0.000%

Managers in the top fifth by current three-year FundScore alpha were net buyers of $0 (0 buying, 0 selling).

Estimated Holder Cost Basis

Quarter ended Jun 30, 2026, on that quarter's share basis

Estimated, never filed: each 13F buy is costed at its quarter's average traded price and each sale keeps the average cost, so this is what holders paid on average if they traded evenly through each quarter.

Estimated avg cost
$9.95
estimated per share
Mar 31, 2026: $6.68
Quarter-end price
$11.50
implied by 13F values
Estimated gain or loss
+15.6%
price against the estimated cost
Estimated at a loss
42.9%
of costed 13F value

Estimated cost covers 99.9% of the 13F shares; positions already held when a filer's 13F history starts, or bought in a quarter without a trusted average price, have no estimate.

Shared Holders

Companies ANL's active holders also own, quarter ended Jun 30, 2026
# Company Shared holders
1 BOLD Boundless Bio, Inc. 5
2 DMRA Damora Therapeutics, Inc. 8
3 RACC Research Alliance Corp III 6
4 NVCT Nuvectis Pharma, Inc. 5
5 XFOR X4 Pharmaceuticals, Inc 6
6 EWTX Edgewise Therapeutics, Inc. 8
7 IKT Inhibikase Therapeutics, Inc. 6
8 EOLS Evolus, Inc. 5
9 GLUE Monte Rosa Therapeutics, Inc. 7
10 CGEM Cullinan Therapeutics, Inc. 6

Shareholder Targets

13F filers that own its peers but not ANL, quarter ended Jun 30, 2026

Found through its holder-overlap peers: BOLD, DMRA, RACC, NVCT, XFOR, EWTX, IKT, EOLS, GLUE, CGEM, LONA, MBX, SABS, IPSC, MAZE, IMVT, PALI, KRRO, CLYM, BIOA. 542 filers in all.

# Filer In peers
1 FMR LLC Holding company, Diversified active $1,578,501,604 18 held
2 BlackRock, Inc. Holding company, Index-like $1,435,801,829 19 held
3 ORBIMED ADVISORS LLC Registered adviser, Diversified active $843,093,796 4 held
4 VANGUARD CAPITAL MANAGEMENT LLC Registered adviser, Index-like $726,440,241 19 held
5 RA CAPITAL MANAGEMENT, L.P. Registered adviser, Concentrated $667,302,808 7 held
6 Deep Track Capital, LP Adviser, Diversified active $617,569,489 5 held
7 STATE STREET CORP Bank, Index-like $602,229,854 19 held
8 Frazier Life Sciences Management, L.P. Registered adviser, Concentrated $559,830,115 4 held
9 Paradigm Biocapital Advisors LP Registered adviser, Concentrated $553,496,364 2 held
10 Jupiter Topco LLC Unknown, Diversified active $514,961,681 10 held

Fund Ownership of ANL by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 0.02% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 0.02% 11,133
Index ETFs 0.00% 0
Active ETFs 0.07% 44,354
Active funds 1.12% 718,747
Unclassified 0.00% 0
All registered funds 1.20% 774,234
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Quarterly Activity

vs Mar 31, 2026
New
22
Increased
9
Decreased
7
Sold Out
6
Unchanged
4

New and Sold Out count only filers that reported a 13F for both quarters: a first-time filer's book is not a buy, and a fund that has not filed, or withheld its positions under confidential treatment, has not sold.

Holder count: +16
Institutional value: +279.5%
Shares held: +128.4%

Top Buyers

vs Mar 31, 2026
Institution Added Now Holds Open

Top Sellers

vs Mar 31, 2026
Institution Sold Now Holds Open

Top New Positions

vs Mar 31, 2026
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Mar 31, 2026
Institution Previously Held Last Value (USD) Open
Showing 42 of 42
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1944552 CUSIP 00704R109 Visit website Investor relations